GSK and MSD to compete vaccines in Korea.

Two leading vaccine manufacturers, GSK and MSD, may stage severe market competition with the cervical cancer and rotavirus vaccines in the world markets as well as Korea market during the times from the 2nd half of this year to the next year.

MSD plans to launch Gardasil (cervix cancer vaccine) and Rotatec (rota virus vaccine) in more than 50 countries over the world during the first half o...